Norlase Obtains FDA and CE Approval for Groundbreaking LYNX™ Laser Indirect Ophthalmoscope Norlase has successfully launched the LYNX™, the first pattern scanning laser indirect ophthalmoscope with FDA and CE approvals, enhancing ophthalmic treatments.

Norlase Obtains FDA and CE Approval for Groundbreaking LYNX™ Laser Indirect Ophthalmoscope #United_States #LYNX #Norlase #Redwood_City,_California #Laser_Ophthalmoscope